drugset / Trial / NCT06969001
Clinical Study for the Evaluation of Safety and Tolerability of SCAI-005 Eye Drops
RandomizedSequentialDouble-blindOther
Summary
To assess the single-dose and multiple-dose pharmacokinetics (PK), safety and tolerability of SCAI-005 eyedrops(axitinib) in healthy volunteers
Timeline
- Start
- 2025-05-29
- Primary completion
- 2025-09-04
- Completion
- 2025-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Axitinib | Small molecule | 0.014 mg | Other |
| Subject | Axitinib | Small molecule | 0.028 mg | Other |
| Subject | Axitinib | Small molecule | 0.056 mg | Other |